For the treatment of major depressive disorder, it appears that SNRIs have an advantage over SSRIs

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1621, 2008-01, pp. : 16-16

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Venlafaxine appears superior to SSRIs in patients with major depressive disorder

Inpharma, Vol. 1, Iss. 1294, 2001-01 ,pp. : 13-14

Adis International

Access to resources Recommend Favorite

Pharmacological Profile of SSRIs and SNRIs in the Treatment of Eating Disorders

Current Clinical Pharmacology, Vol. 4, Iss. 1, 2009-01 ,pp. : 78-83

Bentham Science Publishers

Access to resources Recommend Favorite

Agomelatine for the treatment of major depressive disorder

By Carney Regina M Shelton Richard C

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 15, 2011-10 ,pp. : 2411-2419

Informa Healthcare

Access to resources Recommend Favorite

Duloxetine appears to be efficacious in patients with mild, moderate or severe major depressive disorder

Inpharma, Vol. 1, Iss. 1616, 2007-01 ,pp. : 21-21

Adis International

Access to resources Recommend Favorite

Escitalopram: In the Treatment of Major Depressive Disorder in Adolescent Patients

By Yang Lily P.H. Scott Lesley J.

Pediatric Drugs, Vol. 12, Iss. 3, 2010-06 ,pp. : 155-163

Adis International

Access to resources Recommend Favorite